Home › Lupus Nephritis › Georgia
Lupus Nephritis clinical trials in Georgia
11 studies for Lupus Nephritis are looking for participants at sites in Georgia.
Cities in Georgia
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
- Investigator Site #1, Lawrenceville
RecruitingPhase 2
Ages 16 and older · All sexes · Updated Oct 1, 2026 · NCT06419205VIBRANT: VIB4920 for Active Lupus Nephritis
- Emory University School of Medicine: Division of Rheumatology, Atlanta
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05201469The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Emory Children's Center, Atlanta
RecruitingPhase 2
Ages 8 to 20 · All sexes · Updated Sep 14, 2026 · NCT05538208A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, Atlanta
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Sep 10, 2026 · NCT06897930A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Emory Children's Center, Atlanta
RecruitingPhase 2
Ages 5 to 17 · All sexes · Updated Sep 3, 2026 · NCT05039619RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Emory University, Atlanta
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Aug 26, 2026 · NCT06121297PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Parris and Associates Rheumatology, Lawrenceville
RecruitingPhase 4
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT07611214Wellness & Workforce Solution for Lupus/Lupus Nephritis
- Morehouse School of Medicine, Atlanta
RecruitingHealthy volunteers welcome
Ages 18 and older · Women · Updated Jul 24, 2026 · NCT06217107A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Nkarta Investigational Site, Atlanta
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Jun 4, 2026 · NCT06557265Lupus Landmark Study: A Prospective Registry and Biorepository
- Emory University, Atlanta
RecruitingObservational study
Ages 18 to 110 · All sexes · Updated Apr 15, 2026 · NCT05934149Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
- Piedmont Physicians Rheumatology, Atlanta
- Georgia Nephrology Research Institute, Lawrenceville
- Parris & Associates, Lawrenceville
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Nov 6, 2025 · NCT07225387From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.